Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Pfizer Inc. (PFE) shares rose 1.82% to $28.00 on Wednesday, outperforming the broader market as the S&P 500 and Dow Jones fell. This marks Pfizer's second consecutive day of gains, though it remains 4.14% below its 52-week high. While competitors like Johnson & Johnson, Eli Lilly, and Abbott Laboratories also saw increases, Pfizer's trading volume was lower than its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Pfizer Inc. (PFE) rose 1.82% to $28.00 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.22% to 7,801.77 and Dow Jones Industrial Average falling 0.66% to 51,179.87.
This was the stock's second consecutive day of gains.
Pfizer Inc. closed 4.14% below its 52-week high of $29.21, which the company achieved on September 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 1.44% to $258.45, Eli Lilly & Co. (LLY) rose 2.70% to $1,188.72, and Abbott Laboratories (ABT) rose 0.58% to $98.73.
Trading volume (30.2 M) remained 5.7 million below its 50-day average volume of 35.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 7, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-07-26 1636ET